Kim Y T, Kim J, Jang Y H, Lee W J, Ryu J K, Park Y K, Kim S W, Kim W H, Yoon Y B, Kim C Y
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Cancer Lett. 2001 Aug 10;169(1):59-68. doi: 10.1016/s0304-3835(01)00562-6.
Adenoma and dysplasia in the gallbladder (GB) have been reported as precancerous lesions, but the genetic evidence of this is not clearly defined. The purpose of this study was to analyze the frequencies of K-ras, p53, and p16 gene mutations, of microsatellite instability (MI) and of loss of heterozygosity (LOH) in GB cancer, dysplasia, and adenoma. Tissues from 15 GB cancers, five dysplasias around cancerous tumors, and three adenomas were collected prospectively. The mutation rates of K-ras, p53, and p16 were 20.0, 35.7, and 30.7%, respectively, in GB cancers. However, no mutations were found in dysplasia or adenoma. Reduced staining for p16 was seen in 23% of carcinomas. All of the GB carcinomas and four out of five (80%) of the dysplasias showed LOH in a minimum of one locus, but one out of three (33%) cases of adenoma displayed LOH in only one locus. All of the loci of LOH in the dysplasias, except one, showed the same patterns of allelic loss as the adjacent carcinomas. Only one dysplasia showed multiple MI. In conclusion, multiple LOH may be associated with the development of dysplasia and the malignant transformation of GB carcinoma. Gene alterations of K-ras, p53, and p16 are important steps in the malignant changes of dysplasia. However, MI seems to have only a limited role in GB cancer development.
胆囊(GB)腺瘤和发育异常已被报道为癌前病变,但其遗传学证据尚不明确。本研究的目的是分析K-ras、p53和p16基因突变频率、微卫星不稳定性(MI)以及胆囊癌、发育异常和腺瘤中的杂合性缺失(LOH)情况。前瞻性收集了15例胆囊癌、5例癌旁发育异常组织和3例腺瘤组织。胆囊癌中K-ras、p53和p16的突变率分别为20.0%、35.7%和30.7%。然而,在发育异常或腺瘤中未发现突变。23%的癌组织中p16染色减少。所有胆囊癌和五分之四(80%)的发育异常组织至少在一个位点显示杂合性缺失,但三分之一(33%)的腺瘤病例仅在一个位点显示杂合性缺失。发育异常组织中除一个位点外,所有杂合性缺失位点的等位基因缺失模式与相邻癌组织相同。只有一个发育异常组织显示多个微卫星不稳定性。总之,多个杂合性缺失可能与发育异常的发生及胆囊癌的恶性转化有关。K-ras、p53和p16基因改变是发育异常恶变的重要步骤。然而,微卫星不稳定性在胆囊癌发生中似乎仅起有限作用。